Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan
Ming-Jung Meng,1 Chia-Jung Kuo,1– 5 Ming-Wei Lai,2– 6 Cheng-Tang Chiu,1– 5 Ming-Yao Su,2– 5,7 Ming-Ling Chang,1– 3,5 Puo-Hsien Le1– 5 1Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; 2Chang Gung Inflammatory Bowel Disease Center, Taoyuan, Taiwan; 3Chang...
Saved in:
| Main Authors: | Meng MJ, Kuo CJ, Lai MW, Chiu CT, Su MY, Chang ML, Le PH |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/advanced-combination-therapy-with-biologics-and-upadacitinib-in-refrac-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Therapies in Elderly Patients With Inflammatory Bowel Disease: A Comparative Retrospective Cohort Study in Taiwan
by: Lin SH, et al.
Published: (2025-04-01) -
Impact of Obesity on the Long-Term Outcomes of Advanced Therapies in IBD: A Real-World Study in Taiwan
by: Hsu WC, et al.
Published: (2025-06-01) -
Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn’s Disease: A Case Report
by: Michele Campigotto, et al.
Published: (2025-03-01) -
Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China
by: Xiaoying Wang, et al.
Published: (2025-05-01) -
Advanced therapy screening in inflammatory bowel disease and the impact of clinical nurse specialists: A retrospective analysis of electronic patient records
by: Michael Colwill, et al.
Published: (2025-05-01)